Ulcerative Colitis
📧 Sign up to get email alerts when something new happens for Ulcerative Colitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-02-10Clinical Trial Update: A Phase 2 Study to Evaluate the Efficacy, Safety and Pharmacokinetics of SHR-1139 in Patients With Moderate-to-severe Active Ulcerative Colitis [Phase 2]
Phase 2 clinical trial evaluating SHR-1139 for efficacy, safety, and pharmacokinetics in adults with moderately to severely active ulcerativ…
-
CLINICAL_TRIALS other · 2026-02-09Clinical Trial Update: ACT for Veterans With IBD and Mental Health Challenges [NA]
ClinicalTrials.gov update describes a not-yet-recruiting study evaluating Acceptance and Commitment Therapy for veterans with inflammatory b…
-
CLINICAL_TRIALS research · 2026-02-06Clinical Trial Update: A Study Evaluating the Effects of Filgotinib in Children and Teenagers With Ulcerative Colitis [Phase 3]
Phase 3 clinical trial evaluating the effects of filgotinib in children and adolescents with Ulcerative Colitis is currently recruiting.
-
CLINICAL_TRIALS research · 2026-02-06Clinical Trial Update: A Phase 2 Clinical Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of HRS-7085 Tablets in Patients With Inflammatory Bowel Disease [Phase 2]
Phase 2 clinical trial evaluating the efficacy, safety, and pharmacokinetics of HRS-7085 tablets in adults with moderately to severely activ…
-
CLINICAL_TRIALS trial_result · 2026-02-06Clinical Trial Update: Impact of Telemonitoring in the Management of Complex IBD in Spain: M-TECCU [NA]
A completed clinical trial evaluating telemonitoring in the management of complex inflammatory bowel disease (Crohn's disease and ulcerative…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-02-06Clinical Trial Update: Possible Efficacy and Safety of Mebendazole in Patients With Ulcerative Colitis Treated With Mesalamine [NA]
Ongoing clinical study evaluating the potential efficacy and safety of Mebendazole in Ulcerative Colitis patients already taking Mesalamine;…
-
EMA approval · 2026-02-05EMA Authorised: Yuflyma (adalimumab) — Celltrion Healthcare Hungary Kft.
EMA authorised Yuflyma (adalimumab) as a biosimilar of adalimumab for several inflammatory and autoimmune diseases, including rheumatoid art…
-
CLINICAL_TRIALS research · 2026-02-05Clinical Trial Update: Pregnancy and Inflammatory Bowel Disease
Centre Hospitalier Universitaire, Amiens is sponsoring a recruiting clinical trial addressing inflammatory bowel disease in pregnancy. The s…
-
CLINICAL_TRIALS research · 2026-02-05Clinical Trial Update: Uneven Nutrition and Life Style as IBD Triggers in Adolescents and Adults [NA]
A clinical trial examining whether uneven nutrition and lifestyle factors trigger Crohn's disease or ulcerative colitis in adolescents and a…
-
CLINICAL_TRIALS research · 2026-02-05Clinical Trial Update: Efficacy of Acupuncture-Mesalazine Combination Therapy in Ulcerative Colitis. [NA]
A clinical trial evaluating the efficacy of combining acupuncture with mesalazine for ulcerative colitis; the study is currently not recruit…
-
EMA approval · 2026-02-04EMA Authorised: Imraldi (adalimumab) — Samsung Bioepis NL B.V.
EMA authorised Imraldi, a biosimilar adalimumab by Samsung Bioepis NL B.V., for multiple inflammatory diseases including ankylosing spondyli…
-
CLINICAL_TRIALS research · 2026-02-03Clinical Trial Update: Analysis of Barriers and Facilitators to Adapted Physical Activity for Pediatric Patients With Chronic Inflammatory Bowel Diseases
Clinical trial update describing a study that analyzes barriers and facilitators to adapted physical activity for pediatric patients with ch…
-
CLINICAL_TRIALS research · 2026-02-03Clinical Trial Update: Prophylactic Dexamethasone Before Infliximab in Moderate-to-Severe IBD
An ongoing trial evaluating whether prophylactic dexamethasone before infliximab infusions improves outcomes or reduces reactions in moderat…
-
CLINICAL_TRIALS research · 2026-02-02Clinical Trial Update: Upadacitinib Combined With Corticosteroids vs Corticosteroid Monotherapy Induction for Inpatients and Outpatients With Acute Severe Ulcerative Colitis [Phase 4]
Phase 4 trial comparing induction with upadacitinib plus corticosteroids versus corticosteroid monotherapy in inpatients and outpatients wit…
-
CLINICAL_TRIALS other · 2026-02-02Clinical Trial Update: Acceptability, Adherence, and Impact on the Bioavailability of Iron and Zinc of the Dietary Supplements Goodphyte IB Defense and Goodphyte Immunity in Adults With Chronic Diseases. [NA]
The University of Thessaly-sponsored trial is recruiting to assess acceptability, adherence, and the bioavailability of iron and zinc from t…
-
CLINICAL_TRIALS research · 2026-01-30Clinical Trial Update: Dose-finding Study of SAR443122 in Adult Participants With Ulcerative Colitis [Phase 2]
Phase 2 dose-finding trial of SAR443122 in adults with ulcerative colitis is active/not recruiting, sponsored by Sanofi.
-
CLINICAL_TRIALS research · 2026-01-30Clinical Trial Update: Expanded Access to Upadacitinib
AbbVie’s expanded access program for Upadacitinib is currently AVAILABLE for patients with Crohn's disease, ulcerative colitis, juvenile idi…
-
CLINICAL_TRIALS research · 2026-01-30Clinical Trial Update: LFMT vs Placebo in New Biologic Start for Ulcerative Colitis [Phase 2]
A Phase 2 clinical trial evaluating LFMT versus placebo as a new biologic treatment for ulcerative colitis is currently recruiting.
-
CLINICAL_TRIALS research · 2026-01-30Clinical Trial Update: A Study of Filgotinib 200 mg in Korean Participants With Moderately to Severely Active Ulcerative Colitis Under Routine Clinical Practice [Phase 4]
A Phase 4 study evaluating filgotinib 200 mg in Korean patients with moderate-to-severe ulcerative colitis is currently recruiting in routin…
-
CLINICAL_TRIALS research · 2026-01-29Clinical Trial Update: Desloratadine in Patients With Ulcerative Colitis [Phase 2]
A Phase 2 clinical trial studying desloratadine in patients with ulcerative colitis is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-01-29Clinical Trial Update: R-3750 in Patients With Mild to Moderate Ulcerative Colitis [Phase 1]
Phase 1 clinical trial update for R-3750 in adults with Ulcerative colitis is currently recruiting, sponsored by Rise Therapeutics LLC.
-
CLINICAL_TRIALS research · 2026-01-29Clinical Trial Update: Resistant Starch in Pediatric Inflammatory Bowel Disease (Crohn's Disease or Ulcerative Colitis) [NA]
This is an update on a pediatric clinical trial evaluating resistant starch for Crohn's disease and ulcerative colitis at the Children's Hos…
-
CLINICAL_TRIALS research · 2026-01-29Clinical Trial Update: OptiMized REsistaNt Starch in Inflammatory Bowel Disease: The MEND Trial [NA]
The MEND Trial evaluating OptiMized Resistant Starch for inflammatory bowel disease is listed as active but not recruiting. Target condition…
-
EMA approval · 2026-01-28EMA Authorised: Omvoh (mirikizumab) — Eli Lilly Nederland B.V.
EU authorised Omvoh (mirikizumab) for ulcerative colitis; Eli Lilly Nederland B.V. is the marketing authorisation holder.
-
EMA approval · 2026-01-28EMA Authorised: Hukyndra (adalimumab) — Stada Arzneimittel AG
EMA authorised Hukyndra (adalimumab) from Stada Arzneimittel AG for multiple inflammatory diseases, including rheumatoid arthritis, psoriati…